International Journal of Infectious Diseases
Volume 14, Issue 8 , Pages e698-e703, August 2010

Treatment interruptions among patients with tuberculosis in Russian TB hospitals

  • Evgeny M. Belilovsky

      Affiliations

    • Office of the Special Representative of the WHO Director-General in Russia, Moscow, Russian Federation
  • ,
  • Sergey E. Borisov

      Affiliations

    • Research Institute of Phthisiopulmonology of the Sechenov Moscow Medical Academy, Moscow, Russian Federation
  • ,
  • Earl Francis Cook

      Affiliations

    • Harvard School of Public Health, Boston, USA
  • ,
  • Shimon Shaykevich

      Affiliations

    • Harvard School of Public Health, Boston, USA
  • ,
  • Wieslaw M. Jakubowiak

      Affiliations

    • WHO HQ/TBS/THD, Avenue Appia 20, CH-1211, Geneva 27, Switzerland
    • Corresponding Author InformationCorresponding author. Tel.: +41 22 791 2485; fax: +41 22 791 1589.
  • ,
  • Ekaterina V. Kourbatova

      Affiliations

    • Emory University School of Medicine, Atlanta, USA

Received 3 June 2009; received in revised form 11 March 2010; accepted 12 March 2010. published online 03 June 2010.

Corresponding Editor: Hubert Wong, Vancouver, Canada

Summary 

Objective

To evaluate risk factors for in-patient treatment interruptions (TIs) in Russian tuberculosis (TB) hospitals.

Methods

The regional case-based registers for all TB patients registered in the main regional TB hospitals were analyzed for the period 1993–2002. Multivariable analysis of risk factors for TIs was performed using logistic regression. The prediction rule was developed based on the final multivariable model coefficients obtained from analysis of the largest (Lipetsk) database.

Results

During the study period, 18–50% of new cases and 36–56% of retreatment cases had interrupted in-patient treatment. In multivariate analysis, independent predictors of treatment interruption included: male gender (odds ratios (ORs) 1.5–2.3), age group 25–50 years (ORs 1.5–1.7), alcohol abuse (ORs 1.8–4.0), imprisonment history (ORs 1.3–2.5), unemployment (ORs 1.1–2.8), being a retreatment case (ORs 1.3–2.5), and having severe forms of TB (1.4–4.0); factors protective from interruption included urban residence (ORs 0.7–0.9) and having concomitant diseases (ORs 0.6–0.8). Based on the Lipeck model, new TB cases from the four regions were divided into low, high, and very high risk groups. Proportions of TI were approximately 20–35% in the low risk group, approximately 60–75% in the high risk group, and approximately 75–85% in the very high risk group (except Orel).

Conclusions

We have described the independent predictors of patient TI, and a predictive rule for the in-patient TB treatment phase interruptions has been developed. Treatment interruption is a significant obstacle in the success of the National Tuberculosis Control Program in Russia. Interventions targeted at the high risk groups should be implemented in order to prevent in-patient treatment interruption.

Keywords: Tuberculosis, Hospital treatment interruption, Russia

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1201-9712(10)02342-8

doi:10.1016/j.ijid.2010.03.001

International Journal of Infectious Diseases
Volume 14, Issue 8 , Pages e698-e703, August 2010